- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S6499
| Related Targets | YAP TEAD LATS MST |
|---|---|
| Other MAP4K Inhibitors | NCB-0846 DMX-5084 NDI-101150 BGB 15025 KHK-6 AZ3246 INS018-055(ISM001-055) PF-07265028 CompK KY-05009 |
|
In vitro |
DMSO
: 59 mg/mL
(198.82 mM)
Ethanol : 2 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 296.75 | Formula | C16H13ClN4 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 1811510-56-1 | -- | Storage of Stock Solutions |
|
|
| Synonyms | PF-06260933 | Smiles | C1=CC(=CC=C1C2=C(N=CC(=C2)C3=CN=C(C=C3)N)N)Cl | ||
| Targets/IC50/Ki |
MAP4K4
3.7 nM
|
|---|---|
| In vitro |
This compound demonstrates good physicochemical properties as well as moderate human liver microsomal (HLM) clearance. |
| In vivo |
Following oral dosing (10 mg/kg), PF-6260933 displays a plasma exposure that provided free drug concentrations above the cell IC50 value for about 4-6 h after administration in a mouse model. This compound has suitable PK properties in mouse to be used as a tool in an in vivo model of diabetes. |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.